BioScience Health Innovations, Inc.
OTC · CIK 0001784440 · Fiscal year end 1231
Latest reported period: Latest published period
Revenue
$750,946
Cost Of Revenue
$265,350
Gross Profit
$485,596
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $750,946 | - | - |
| Cost Of Revenue | $265,350 | - | - |
| Gross Profit | $485,596 | - | - |
| Operating Income | $-229,907 | - | - |
| Net Income | $-229,907 | - | - |
| Eps Basic | -0.02 | - | - |
| Eps Diluted | -0.02 | - | - |
| Cash And Equivalents | $1.1M | - | - |
| Total Assets | $2.3M | - | - |
| Total Liabilities | $645,749 | - | - |
| Shareholders Equity | $1.7M | - | - |
| Operating Cash Flow | $-552,107 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | BioScience Health Innovations, Inc. | 2026-05-11 | 0001185185-26-001775 |
| 10-K | BioScience Health Innovations, Inc. | 2026-03-30 | 0001185185-26-001133 |
| 10-Q | BioScience Health Innovations, Inc. | 2025-10-27 | 0001185185-25-001545 |
| 10-Q | BioScience Health Innovations, Inc. | 2025-08-07 | 0001185185-25-000908 |